Apnicaf Injection

Caffeine
20mg
Abbott India Ltd.
Pack size
Dispensing mode
Source
Agent
Retail Price

Available as:

Indications

Apnicaf Injection is used for: Migraine, Mild stimulant of the central nervous system, Short-term treatment of neonatal apnoea of prematurity

Adult Dose

Oral Migraine Adult: 100 mg in combination with ergotamine. Mild stimulant of the central nervous system Adult: 50-100 mg up to 200 mg. Not to be taken more often than 3 hrly. Max: 1 g/day. Max Dosage: 1 g daily.

Child Dose

Intravenous Short-term treatment of neonatal apnoea of prematurity Child: As citrate: 20 mg/kg (equivalent to 10 mg/kg caffeine) via IV infusion. Maintenance: 5 mg/kg daily. May also be given orally.

Renal Dose

Administration

May be taken with or without food.

Contra Indications

Hypersensitivity.

Precautions

Peptic ulceration; symptomatic cardiac arrhythmias and/or palpitations; 1st several days to wk after an acute MI; neonates; pregnancy; lactation.

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Caffeine : Insomnia, restlessness, nervousness, mild delirium; nausea, vomiting, gastric irritation.

Mechanism of Action

Caffeine, a methylxanthine, is a phosphodiesterase inhibitor. It has an antagonistic effect at central adenosine receptors. It is a CNS and resp stimulant. It has bronchodilating and diuretic properties and it facilitates the performance of muscular work.

Note

Apnicaf 20mg Injection manufactured by Abbott India Ltd.. Its generic name is Caffeine. Apnicaf is availble in Nepal. Farmaco Nepal drug index information on Apnicaf Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Caffeine :